Article
SIRPα+ PD-L1+ bone marrow macrophages aid AML growth by modulating T cell function
2024-09-19
Abstract excerpt
Acute myeloid leukemia (AML) continues to have a poor prognosis due to its ability to relapse following initial response to chemotherapy. While immunotherapies hold the promise to revolutionize cancer treatment, AML has been particularly challenging to target. It is therefore important to better understand the relationship between AML cells and immune cells within the bone marrow (BM) microenvironment, where this...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 366a5fcf-df83-5165-bbf8-fb720b9ad177
- DOI
- 10.1101/2024.09.15.613123
